From Fibroids to Hysterectomy

Understanding the Hidden Cost of Surgical Menopause for Black Women

It rarely begins with the word “surgery.” It begins with being told to manage. To cope. To wait.

For many women, particularly Black women, the early signs are familiar. Heavy bleeding that interrupts daily life, pain that is normalised, fatigue that is dismissed. Over time, these “manageable” symptoms accumulate, quietly shaping decisions, limiting options and narrowing the pathway forward. By the time a full hysterectomy is presented, it is often framed not as one option among many, but as the only viable solution.

From Hysterectomy to Surgical Menopause

A full hysterectomy involves the removal of the womb (uterus). However, menopause is not automatically triggered unless the ovaries are also removed. When both ovaries are taken out, most commonly during a combined procedure such as Total Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH + BSO), this induces surgical menopause.

Unlike natural menopause, which unfolds gradually over several years, surgical menopause begins immediately. The body experiences an abrupt and significant drop in estrogen, progesterone and testosterone, creating a physiological shift that is both sudden and profound.

Why Surgical Menopause Feels So Intense

This immediacy is what makes the experience so intense. Without the gradual hormonal transition seen in natural menopause, the body has no time to recalibrate. Women often report severe hot flushes and night sweats, alongside anxiety, mood changes, cognitive fog and disrupted sleep.

There are also longer-term implications. Loss of libido, sexual dysfunction, increased cardiovascular risk and accelerated bone density loss leading to osteoporosis. These effects are particularly pronounced in younger women, especially those under 45, where premature hormonal change can alter long-term health trajectories.

For many Black women in our communities, this pathway is not an outlier, it is a pattern.

Conditions such as fibroids, heavy menstrual bleeding and chronic pelvic pain are often experienced earlier, more severely and for longer periods without effective intervention. Research consistently shows that Black women are more likely to develop fibroids at a younger age, experience more aggressive symptoms and are more likely to undergo hysterectomy as a result.

This is where the narrative deepens. Surgical menopause is not simply a medical outcome,  it is often the end point of a prolonged journey through fragmented care.

Many Black women describe years of not being heard, of symptoms being minimised and of not being offered the full range of treatment options early enough. By the time surgery is introduced, the decision is shaped as much by systemic delay as it is by clinical need. The consequence is immediate menopause, an abrupt hormonal shift layered onto years of unmanaged strain.

The Ripple Effect Beyond Health

The impact does not stop at the clinical level. It moves into the workplace, affecting performance, confidence and progression. It shapes relationships, mental health and long-term financial stability. When menopause is forced rather than prepared for, the cost becomes cumulative, carried across health, identity and opportunity.

This is why this conversation must be reframed. It is not only about menopause, it is about equity in care, accountability in systems and the leadership required to intervene earlier.

When one group of women is consistently more likely to reach this point, not by chance, but through patterns of delayed diagnosis and limited access to alternatives, the outcome is not incidental. It is structural.

What is beginning to emerge across health systems, including NHS women’s health hubs, is a shift toward earlier intervention and more integrated care. The critical question now is whether that shift will be fast enough, and equitable enough, to change outcomes for Black women before surgical menopause becomes the default rather than the last resort.

Let us set out what surgical menopause means in real terms, the cost attached to it and why addressing its disproportionate impact on Black women is no longer optional, it is essential.

The Fibroid Factor

There is no disputing that the disproportionate impact on Black women begins much earlier in the clinical pathway, most notably with fibroids. By the age of 50, around 80 percent of Black women will have developed fibroids, often at a younger age and with more aggressive growth patterns. This earlier onset extends the duration and severity of symptoms such as heavy bleeding, pelvic pain and anaemia, increasing the likelihood of escalation to surgical intervention.

Fibroids remain the leading cause of hysterectomy and Black women are estimated to be two to three times more likely to undergo surgery as a result. What appears to be a clinical endpoint is often shaped by a sequence of earlier missed opportunities, delayed recognition, limited intervention and constrained treatment pathways, which ultimately increase the likelihood of surgical menopause.

These outcomes are further intensified by systemic barriers within care delivery. Evidence continues to show that Black women are more likely to experience delays in diagnosis, have their symptoms minimised and are less frequently offered minimally invasive or uterus-sparing procedures at an early stage. As a result, by the time specialist care is accessed, conditions have often progressed beyond conservative management.

The Economic and Workforce Impact

The implications extend beyond health into economic and workforce participation. In the UK, fibroids and related gynaecological conditions contribute to an estimated £11 billion annually in lost productivity, while menopause-related symptoms account for approximately £1.5 billion in unemployment costs.

When menopause is surgically induced, often earlier and more abruptly, the impact on physical health, cognitive function, workplace performance and long-term financial stability becomes more pronounced. Within this context, informed clinical dialogue and self-advocacy are not optional,  they are critical.

Informed Decisions Change Outcomes

Understanding the full range of treatment options, including minimally invasive approaches, the implications of surgical menopause, the role of hormone replacement therapy and pre-surgical health considerations such as anaemia and vitamin deficiencies, can materially influence outcomes.

Equally, access to culturally competent care and community-based support networks plays a vital role in ensuring that women are not navigating these decisions in isolation, but with the knowledge, confidence and backing required to make informed, future-focused choices.

A Call to Advocate for Your Health

Your experience matters. Your health matters.

In a system where too many Black women have had to fight to be heard, silence is no longer a sustainable option. What we are seeing is not just a series of individual health journeys, but a pattern that calls for collective awareness, informed decision-making and stronger advocacy. When women are equipped with the right information, the right questions and the right support, the pathway can change, earlier intervention becomes possible, more options remain available and outcomes improve.

Advocacy, in this context, is both personal and powerful.

• It begins with paying attention to your body tracking symptoms, noticing patterns and being able to clearly articulate changes over time.

• It means not attending appointments alone when you feel uncertain, seeking second opinions when answers do not feel complete and asking directly for care that is culturally competent and responsive to your lived experience.

• It also means engaging with trusted networks, where shared knowledge and support circles can provide both clarity and confidence during what can often feel like an isolating process.

Questions That Protect Your Future Health

Equally important is the quality of the clinical conversation. Knowing what to ask can reshape the care you receive:

• What are all the available treatment options and have all alternatives to surgery been fully explored?

• Is minimally invasive surgery suitable in your case?

• If surgical menopause is being considered, what will that mean for your body, your mental wellbeing and your long-term health?

• Should hormone replacement therapy be part of your care plan and how will this decision affect your cardiovascular and bone health over time?

• Are there underlying factors, such as anaemia or vitamin D deficiency, that should be addressed before any procedure takes place?

These are not peripheral questions,  they are central to protecting your health now and in the future.

Moving Forward Together

Together, we have an opportunity to shift the narrative, to move from delayed responses to proactive care, from limited options to informed choice and from silence to a collective voice that demands better. If this resonates with your experience or someone you support, do not navigate it alone.

---

Connect with the MenopauseTalk Group for further information, guidance, resources and a community that understands the intersection of health, leadership and lived experience.